ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice

European Journal of Immunology

Volumn 45, Issue 10, 2015, Pages 2766-2772

  Paclik, Daniela ^a   Stehle, Christina ^a   Lahmann, Annette ^a   Hutloff, Andreas ^a,b   Romagnani, Chiara ^a  

^a POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

GATA3; ICOS; IL 33; ILC2; Innate lymphoid cell

Indexed keywords

INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; ICOS PROTEIN, MOUSE; IL33 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; EFFECTOR CELL; EOSINOPHIL; FEMALE; HELMINTHIASIS; HOMEOSTASIS; HUMORAL IMMUNITY; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY; INTESTINE; LUNG; MUTANT MOUSE STRAIN; PHYSIOLOGY;

ANIMALS; HOMEOSTASIS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INFLAMMATION; INTERLEUKIN-33; INTESTINES; LUNG; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 84943198767     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545635     Document Type: Article

References (33)

1. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S. et al., Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013. 13: 145-149.
2. Annunziato, F., Romagnani, C. and Romagnani, S., The 3 major types of innate and adaptive cell-mediated effector immunity. J. Allergy Clin. Immunol. 2014. 135: 626-635.
3. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S. et al., IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001. 15: 985-995.
4. Walker, J. A. and McKenzie, A. N., Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 2013. 25: 148-155.
5. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J. et al., Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010. 463: 540-544.
6. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., Bucks, C. et al., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010. 464: 1367-1370.
7. Price, A. E., Liang, H. E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J. and Locksley, R. M., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 2010. 107: 11489-11494.
8. Kim, H. Y., Chang, Y. J., Subramanian, S., Lee, H. H., Albacker, L. A., Matangkasombut, P., Savage, P. B. et al., Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 2012. 129: 216-227, e211-e216.
9. Mjosberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., vanDrunen, C. M., Piet, B., Fokkens, W. J. et al., Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011. 12: 1055-1062.
10. Nussbaum, J. C., VanDyken, S. J., vonMoltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E. et al., Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013. 502: 245-248.
11. Mjosberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., te Velde, A. A. et al., The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012. 37: 649-659.
12. Yu, X., Pappu, R., Ramirez-Carrozzi, V., Ota, N., Caplazi, P., Zhang, J., Yan, D. et al., TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 2014. 7: 730-740.
13. Meylan, F., Hawley, E. T., Barron, L., Barlow, J. L., Penumetcha, P., Pelletier, M., Sciume, G. et al., The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 2014. 7: 958-968.
14. Simpson, T. R., Quezada, S. A. and Allison, J. P., Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr. Opin. Immunol. 2010. 22: 326-332.
15. Akiba, H., Takeda, K., Kojima, Y., Usui, Y., Harada, N., Yamazaki, T., Ma, J. et al., The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 2005. 175: 2340-2348.
16. Bossaller, L., Burger, J., Draeger, R., Grimbacher, B., Knoth, R., Plebani, A., Durandy, A. et al., ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 2006. 177: 4927-4932.
17. Weber, J. P., Fuhrmann, F., Feist, R. K., Lahmann, A., Al Baz, M. S., Gentz, L. J., Vu Van, D. et al., ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J. Exp. Med. 2015. 212: 217-233.
18. Hutloff, A., Büchner, K., Reiter, K., Baelde, H. J., Odendahl, M., Jacobi, A., Dorner, T. and Kroczek, R. A., Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 2004. 50: 3211-3220.
19. Yu, D., Tan, A. H., Hu, X., Athanasopoulos, V., Simpson, N., Silva, D. G., Hutloff, A. et al., Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007. 450: 299-303.
20. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K., Doherty, J. M. et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722-725.
21. McAdam, A. J., Greenwald, R. J., Levin, M. A., Chernova, T., Malenkovich, N., Ling, V., Freeman, G. J. and Sharpe, A. H., ICOS is critical for CD40-mediated antibody class switching. Nature 2001. 409: 102-105.
22. Hoyler, T., Klose, C. S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E. L., Voehringer, D. et al., The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012. 37: 634-648.
23. Frey, O., Meisel, J., Hutloff, A., Bonhagen, K., Bruns, L., Kroczek, R. A., Morawietz, L. and Kamradt, T., Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann. Rheum. Dis. 2010. 69: 1495-1501.
24. Logue, E. C., Bakkour, S., Murphy, M. M., Nolla, H. and Sha, W. C., ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9. J. Immunol. 2006. 177: 2356-2364.
25. Marczynska, J., Ozga, A., Wlodarczyk, A., Majchrzak-Gorecka, M., Kulig, P., Banas, M., Michalczyk-Wetula, D. et al., The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses. J. Immunol. 2014. 193: 2753-2763.
26. Swallow, M. M., Wallin, J. J. and Sha, W. C., B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 1999. 11: 423-432.
27. Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G. et al., T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999. 402: 827-832.
28. Burmeister, Y., Lischke, T., Dahler, A. C., Mages, H. W., Lam, K. P., Coyle, A. J., Kroczek, R. A. and Hutloff, A., ICOS controls the pool size of effector-memory and regulatory T cells. J. Immunol. 2008. 180: 774-782.
29. Maazi, H., Patel, N., Sankaranarayanan, I., Suzuki, Y., Rigas, D., Soroosh, P., Freeman, G. J. et al., ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 2015. 42: 538-551.
30. Kamachi, F., Isshiki, T., Harada, N., Akiba, H. and Miyake, S., ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem. Biophy.s Res. Commun. 2015. 463: 739-745.
31. Yao, S., Zhu, Y. and Chen, L., Advances in targeting cell surface signalling molecules for immune modulation. Nat. Rev. Drug Discov. 2013. 12: 130-146.
32. Özkaynak, E., Gao, W., Shemmeri, N., Wang, C., Gutierrez-Ramos, J. C., Amaral, J., Qin, S. et al., Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2001. 2: 591-596.
33. Wong, S. C., Oh, E., Ng, C. H. and Lam, K. P., Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2. Blood 2003. 102: 1381-1388.